- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr John Fox Discusses Expanding Comprehensive Genomic Profiling Across Several Cancers
John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's call to expand comprehensive genomic testing across several cancers.
John Fox, MD, MHA, vice president of cinical transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's (NCCN's) call to expand comprehensive genomic testing across several cancers.
Transcript
At the most recent NCCN Annual Meeting, guidelines called for expanded comprehensive molecular profiling across several cancers. Do these changes present new reimbursement challenges?
The NCCN has recommended that we do comprehensive molecular profiling on more and more cancer types. It’s fascinating because the cost of genomic profiling is now in the range of $2500 to $3000. If you look at the cost of the therapies we’re using, they may be, if you’re using a monoclonal antibody, $8000, $10,000, $15,000 a month, and if we’re using those in combination, it’s even more. So, if in fact those molecular profiles help better identify which patients are likely to respond to which therapies, it’s a good value, because they’re spending thousands, tens of thousands of dollars a month on treatment, that if ineffective, is a waste of dollars and a waste of resources and a cost to the patient.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
